Cancer statistics, 2016
By R. Siegel, K. Miller, A. Jemal. Ca, 2016
14,496 citations recorded by the source corpus.
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009‐2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth‐19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2016;7–30. © 2015 American Cancer Society.
Subfields: Economics and Econometrics, Oncology
View Paper: https://www.semanticscholar.org/paper/02e70a69005abf21219271f460161ea4d1650dd9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
In Oncology
Citations in the corpus
- Skin lesion classification from dermoscopic images using deep learning techniques (2017, background): “There are an estimated 76,380 new cases of melanoma and an estimated 6,750 deaths each year in the United States [1].”
- Circular RNA and its mechanisms in disease: From the bench to the clinic. (2018, positive): “Moreover, the level of hsa_circ_0001564 is increased in osteosarcoma tissues and contributes to tumorigenicity by sponging miR-29c-3p (Song & Li, 2018).”
- The landscape of genomic alterations across childhood cancers (2018, neutral): “…(914 individual patients) from previous cancer-type specific studies (see Methods and Supplementary Note 1) including 547 whole-genome sequences (WGS, median coverage 37 × ) and 414 whole-exome sequences (WES, 121 × ) partially complemented by low-coverage whole genomes (Supplementary Tables 1, 2).”
- Metallothionein-1G Facilitates Sorafenib Resistance through Inhibition of Ferroptosis (2016, background): “The incidence of HCC is increasing in developed countries (including the United States and countries in Europe) because of the progression of old hepatitis C viral infections, alcohol consumption, the almost epidemic prevalence of obesity, and metabolic syndrome-associated nonalcoholic fatty liver d”
- Automatic Skin Lesion Segmentation Using Deep Fully Convolutional Networks With Jaccard Distance (2017, background): “mated new cases of 76, 380 and estimated death of 10, 130 in the United States in 2016 [1].”